Central America Pharmaceuticals and Healthcare Industry Update Quarter 3 2012
$ 1 088
- May 2013
- by Business Monitor International
- 73
Includes 3 FREE quarterly updates
BMI View: Commercial incentives for foreign drugmakers to expand in the Central American
pharmaceutical market are limited by the region's relatively low per capita pharmaceutical spending and
market growth. However, the heavy reliance on imported medicine in the region provides revenuegenerating
opportunities for generic drugmakers from neighbouring Latin American countries and India.
We believe that Costa Rica will continue to attract investment as a regional pharmaceutical production hub.
We also highlight that Panama can be a premier country in the region for foreign drugmakers to expand
their presence.
Headline Expenditure Projections
• Pharmaceuticals: US$3.4bn in 2012 to US$3.6bn in 2013; +5.5% in US dollar terms. Our forecast has
been revised slightly downwards since Q213 due to new historical data.
• Healthcare: US$15.0bn in 2012 to US$16.3bn in 2013; +8.5% in US dollar terms. Our forecast has
been revised upwards since Q213 due to improved historical data.
BMI Industry View 7
SWOT 9
SWOT 9
SWOT : Political 10
SWOT : Economic 11
Industry Forecast 12
Pharmaceutical Market Forecast 12
Table: Pharmaceutical Sales Indicators 13
Guatemala 13
Table: Guatemala Pharmaceutical Sales Forecasts 13
Costa Rica 14
Table: Costa Rica Pharmaceutical Sales Forecasts 14
El Salvador 15
Table: El Salvador Pharmaceutical Sales Forecasts 15
Honduras 17
Table: Honduras Pharmaceutical Sales Forecasts 17
Panama 18
Table: Panama Pharmaceutical Sales Forecasts 18
Nicaragua 19
Table: Nicaragua Pharmaceutical Sales Forecasts 19
Belize 20
Table: Belize Pharmaceutical Sales Forecasts 20
Healthcare Forecast 21
Guatemala 22
Table: Guatemala Healthcare Expenditure Forecasts 22
Costa Rica 23
Table: Costa Rica Healthcare Expenditure Forecasts 23
El Salvador 24
Table: El Salvador Healthcare Expenditure Forecasts 25
Panama 26
Table: Panama Healthcare Expenditure Forecasts 26
Honduras 27
Table: Honduras Healthcare Expenditure Forecasts 27
Nicaragua 28
Table: Nicaragua Healthcare Expenditure Forecasts 28
Belize 29
Table: Belize Healthcare Expenditure Forecasts 29
Pharmaceutical Trade Forecast 30
Guatemala 31
Table: Guatemala Pharmaceutical Trade Data And Forecasts (US$mn) 31
Costa Rica 31
Table: Costa Rica Pharmaceutical Trade Data And Forecasts (US$mn) 32
El Salvador 33
Table: El Salvador Pharmaceutical Trade Data And Forecasts (US$mn) 33
Panama 34
Table: Panama Pharmaceutical Trade Data And Forecasts (US$mn) 34
Honduras 35
Table: Honduras Pharmaceutical Trade Data And Forecasts (US$mn) 35
Nicaragua 35
Table: Nicaragua Pharmaceutical Trade Data And Forecasts (US$mn) 36
Belize 36
Industry Risk Reward Ratings 37
Americas Risk/Reward Ratings 37
Central America Industry Risk/Reward Ratings 41
Industry Trends And Developments 43
Regional Developments 43
Guatemala 43
Costa Rica 45
El Salvador 48
Panama 49
Honduras 50
Nicaragua 51
Belize 53
Epidemiology 53
Clinical Trials 55
Regulatory Development 58
Regulatory Regime 58
Intellectual Property Regime 58
Costa Rica 59
El Salvador 60
Honduras 60
Nicaragua 61
Panama 61
Guatemala 61
Competitive Landscape 62
Company Profile 63
Ancalmo Internacional 63
Donovan Werke 65
Glossary 67
Methodology 69
Methodology 69
Pharmaceutical Expenditure Forecast Model 69
Healthcare Expenditure Forecast Model 69
Notes On Methodology 70
Risk/Reward Ratings Methodology 71
Ratings Overview 72
Table: Pharmaceutical Risk/Reward Ratings Indicators 72
Indicator Weightings 73
Pharmaceutical in World
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pharmaceutical
- Countries : Cuba, World
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pharmaceutical
- Countries : Fiji, World
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pharmaceutical
- Countries : World
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pharmaceutical
- Countries : Iran, World
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pharmaceutical
- Countries : World